RESUMEN
MOTIVATION: Chemical cross-linking coupled to mass spectrometry (XLMS) emerged as a powerful technique for studying protein structures and large-scale protein-protein interactions. Nonetheless, XLMS lacks software tailored toward dealing with multiple conformers; this scenario can lead to high-quality identifications that are mutually exclusive. This limitation hampers the applicability of XLMS in structural experiments of dynamic protein systems, where less abundant conformers of the target protein are expected in the sample. RESULTS: We present QUIN-XL, a software that uses unsupervised clustering to group cross-link identifications by their quantitative profile across multiple samples. QUIN-XL highlights regions of the protein or system presenting changes in its conformation when comparing different biological conditions. We demonstrate our software's usefulness by revisiting the HSP90 protein, comparing three of its different conformers. QUIN-XL's clusters correlate directly to known protein 3D structures of the conformers and therefore validates our software. AVAILABILITYAND IMPLEMENTATION: QUIN-XL and a user tutorial are freely available at http://patternlabforproteomics.org/quinxl for academic users. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
Asunto(s)
Proteínas , Programas Informáticos , Espectrometría de Masas , Conformación Proteica , Reactivos de Enlaces Cruzados/químicaRESUMEN
We present RawVegetable, a software for mass spectrometry data assessment and quality control tailored toward shotgun proteomics and cross-linking experiments. RawVegetable provides four main modules with distinct features: (A) The charge state chromatogram that independently displays the ion current for each charge state; useful for optimizing the chromatography for highly charged ions and with lower XIC values such as those typically found in cross-linking experiments. (B) The XL-Artefact determination, which flags possible noncovalently associated peptides. (C) The TopN density estimation, for detecting retention time intervals of under or over-sampling, and (D) The chromatography reproducibility module, which provides pairwise comparisons between multiple experiments. RawVegetable, a tutorial, and the example data are freely available for academic use at: http://patternlabforproteomics.org/rawvegetable. SIGNIFICANCE: Chromatography optimization is a critical step for any shotgun proteomic or cross-linking mass spectrometry experiment. Here, we present a nifty solution with several key features, such as displaying individual charge state chromatograms, highlighting chromatographic regions of under- or over-sampling and checking for reproducibility.
Asunto(s)
Proteómica , Programas Informáticos , Espectrometría de Masas , Péptidos , Reproducibilidad de los ResultadosRESUMEN
We present the Mixed-Data Acquisition (MDA) strategy for mass spectrometry data acquisition. MDA combines Data-Dependent Acquisition (DDA) and Data-Independent Acquisition (DIA) in the same run, thus doing away with the requirements for separate DDA spectral libraries. MDA is a natural result from advances in mass spectrometry, such as high scan rates and multiple analyzers, and is tailored toward exploiting these features. We demonstrate MDA's effectiveness on a yeast proteome analysis by overcoming a common bottleneck for XIC-based label-free quantitation; namely, the coelution of precursors when m/z values cannot be distinguished. We anticipate that MDA will become the next mainstream data generation approach for proteomics. MDA can also serve as an orthogonal validation approach for DDA experiments. Specialized software for MDA data analysis is made available on the project's website.
Asunto(s)
Proteoma , Proteómica , Espectrometría de Masas , Programas InformáticosRESUMEN
A simple and low-cost multipurpose analytical method using HPLC-UV-DAD was developed and validated, following international guidelines, for the determination of six synthetic food dyes: Tartrazine, Sunset Yellow, Amaranth, Allura Red, Indigotine, and Brilliant Blue. The method required a simple sample preparation step that consisted of dissolution or dilution of the samples in water, followed by pH adjustment and filtering through PVDF filters. No significant matrix effect was verified. Linear working ranges varied from 0.25 to 6.0 mg L-1. Appropriate limits of quantification (0.10 to 0.15 mg L-1), mean recoveries (90.2 to 106.6%), and repeatability and intermediate precision (<4.5%) were obtained. Sixty-one samples of different types of foodstuffs were analyzed: jelly and juice powder, jelly candy, jujube candy, hard candy, ice cream syrup, sports drinks, soft drinks, energy drinks, artificially colored ready-to-drink fruit juices and flavored alcoholic beverages. All studied samples showed dye levels in conformity with Brazilian regulations.
RESUMEN
A highly sensitive analytical method was developed and validated, following international guidelines, for the determination of the residues of five macrocyclic lactones (MLs) (abamectin, doramectin, eprinomectin, ivermectin and moxidectin) in cheese. The extracts were concentrated by rotary-evaporation and derivatized; no clean-up was necessary. Despite matrix complexity, no significant matrix-effect was verified, and standards were prepared in solvents. Linear working ranges varied from 0.25 to 5.0⯵gâ¯L-1. Excellent limits of quantification (0.58-0.87⯵gâ¯kg-1), mean recoveries (91-103%), and repeatability and intermediate precision (<5.8%) were obtained. Twenty-two samples of bovine and non-bovine cheeses were analyzed. Twenty-one samples showed residues of at least one ML (between 0.59 and 15.3⯵gâ¯kg-1), but moxidectin was never detected; a sample of mozzarella was free of MLs. To the best of our knowledge, this is the first method describing the simultaneous evaluation of these MLs in cheese using HPLC and fluorescence detection.
Asunto(s)
Queso/análisis , Análisis de los Alimentos/métodos , Lactonas/análisis , Lactonas/aislamiento & purificación , Límite de Detección , Compuestos Macrocíclicos/química , Espectrometría de Fluorescencia , Animales , Antibacterianos/análisis , Antibacterianos/química , Antibacterianos/aislamiento & purificación , Bovinos , Cromatografía Líquida de Alta Presión , Frío , Contaminación de Alimentos/análisis , Lactonas/química , Extracción en Fase Sólida , Factores de TiempoRESUMEN
Breast cancer arising in very young patients may be biologically distinct; however, these tumors have been less well studied. We characterized a group of very young patients (≤ 35 years) for BRCA germline mutation and for somatic mutations in luminal (HER2 negative) breast cancer. Thirteen of 79 unselected very young patients were BRCA1/2 germline mutation carriers. Of the non-BRCA tumors, eight with luminal subtype (HER2 negative) were submitted for whole exome sequencing and integrated with 29 luminal samples from the COSMIC database or previous literature for analysis. We identified C to T single nucleotide variants (SNVs) as the most common base-change. A median of six candidate driver genes was mutated by SNVs in each sample and the most frequently mutated genes were PIK3CA, GATA3, TP53 and MAP2K4. Potential cancer drivers affected in the present non-BRCA tumors include GRHL2, PIK3AP1, CACNA1E, SEMA6D, SMURF2, RSBN1 and MTHFD2. Sixteen out of 37 luminal tumors (43%) harbored SNVs in DNA repair genes, such as ATR, BAP1, ERCC6, FANCD2, FANCL, MLH1, MUTYH, PALB2, POLD1, POLE, RAD9A, RAD51 and TP53, and 54% presented pathogenic mutations (frameshift or nonsense) in at least one gene involved in gene transcription. The differential biology of luminal early-age onset breast cancer needs a deeper genomic investigation.
RESUMEN
The importance of tumor-stromal cell interactions in breast tumor progression and invasion is well established. Here, an evaluation of differential genomic profiles of carcinoma-associated fibroblasts (CAFs) compared to fibroblasts derived from tissues adjacent to fibroadenomas (NAFs) revealed altered focal adhesion pathways. These data were validated through confocal assays. To verify the possible role of fibroblasts in lymph node invasion, we constructed a tissue microarray consisting of primary breast cancer samples and corresponding lymph node metastasis and compared the expression of adhesion markers RhoA and Rac1 in fibroblasts located at these different locations. Two distinct tissue microarrays were constructed from the stromal component of 43 primary tumors and matched lymph node samples, respectively. Fibroblasts were characterized for their expression of α-smooth muscle actin (α-SMA) and vimentin. Moreover, we verified the level of these proteins in the stromal compartment from normal adjacent tissue and in non-compromised lymph nodes. Our immunohistochemistry revealed that 59 % of fibroblasts associated with primary tumors and 41 % of the respective metastatic lymph nodes (p = 0.271) displayed positive staining for RhoA. In line with this, 57.1 % of fibroblasts associated with primary tumors presented Rac1-positive staining, and the frequency of co-positivity within the lymph nodes was 42.9 % (p = 0.16). Expression of RhoA and Rac1 was absent in fibroblasts of adjacent normal tissue and in compromised lymph nodes. Based on our findings that no significant changes were observed between primary and metastatic lymph nodes, we suggest that fibroblasts are active participants in the invasion of cancer cells to lymph nodes and support the hypothesis that metastatic tumor cells continue to depend on their microenvironment.
Asunto(s)
Neoplasias de la Mama/genética , Invasividad Neoplásica/genética , Proteína de Unión al GTP rac1/biosíntesis , Proteína de Unión al GTP rhoA/biosíntesis , Adulto , Anciano , Anciano de 80 o más Años , Neoplasias de la Mama/patología , Línea Celular Tumoral , Femenino , Fibroblastos/patología , Regulación Neoplásica de la Expresión Génica , Humanos , Ganglios Linfáticos/metabolismo , Ganglios Linfáticos/patología , Metástasis Linfática , Persona de Mediana Edad , Invasividad Neoplásica/patología , Proteína de Unión al GTP rac1/genética , Proteína de Unión al GTP rhoA/genéticaRESUMEN
Este artigo tem como objetivo fazer uma revisão de literatura, analisando a microbiologia do biofilme presente nas próteses totais e seus diversos métodos de higienização para prevenir algumas patologias que estão relacionadas com sua formação. Foi utilizado o banco de dados Pubmed e os descritores prosthodontics, microbiology, denture e biofilm. Dentre todos os estudos avaliados, a utilização do hipoclorito de sódio, a 2% e a 0,05%, associado ou não ao sabão de coco, se apresenta como uma forma eficaz de higienização da prótese, diminuindo o biofilme e algumas espécies patogênicas. Concluímos que a indicação do agente de limpeza protética deve ir ao encontro da necessidade do paciente, sendo sempre um com o melhor custo benefício, de fácil utilização e biocompatível.
This article aims to make a literature review, analyzing microbiology of this biofilm in complete dentures and its various cleaning methods to prevent some diseases that are related to their training. We used the Pubmed database and prosthodontics descriptors, microbiology, and denture biofilm. Among all the studies evaluated the use of sodium hypochlorite, 2% and 0.05%, with or without the coconut soap, is presented as an effective way of cleaning the prosthesis, reducing the biofilm and some pathogenic species. We conclude that the indication of prosthetic cleaning agent should meet the needs of the patient, always one with the best value for money, easy to use and biocompatible.
Asunto(s)
Higiene Bucal/métodos , Prótesis Dental , Cocos , Biopelículas , Dentadura Completa , MicrobiologíaRESUMEN
Cancer-associated fibroblasts (CAF) influence tumor development at primary as well as in metastatic sites, but there have been no direct comparisons of the transcriptional profiles of stromal cells from different tumor sites. In this study, we used customized cDNA microarrays to compare the gene expression profile of stromal cells from primary tumor (CAF, n = 4), lymph node metastasis (N+, n = 3) and bone marrow (BM, n = 4) obtained from breast cancer patients. Biological validation was done in another 16 samples by RT-qPCR. Differences between CAF vs N+, CAF vs BM and N+ vs BM were represented by 20, 235 and 245 genes, respectively (SAM test, FDR < 0.01). Functional analysis revealed that genes related to development and morphogenesis were overrepresented. In a biological validation set, NOTCH2 was confirmed to be more expressed in N+ (vs CAF) and ADCY2, HECTD1, HNMT, LOX, MACF1, SLC1A3 and USP16 more expressed in BM (vs CAF). Only small differences were observed in the transcriptional profiles of fibroblasts from the primary tumor and lymph node of breast cancer patients, whereas greater differences were observed between bone marrow stromal cells and the other two sites. These differences may reflect the activities of distinct differentiation programs.
RESUMEN
BACKGROUND & AIMS: High concentration of 1,25(OH)2D3 (50-100 nM), which cause hypercalcemia in vivo, induce the hormone transcriptional targets and exert antiproliferative effects in cultured breast cancer lineages, however, no studies investigated whether these effects might be reproduced in tumor specimens in vivo. Our aim was to evaluate the effects of calcitriol supplementation on the proliferative index (Ki67 expression) and gene expression profile of post-menopausal breast cancer samples. METHODS & RESULTS: Tumor samples were collected from 33 patients, most of whom (87.5%) presenting 25(OH)D3 insufficiency, before and after a short term calcitriol supplementation (0.50 µg/day PO, for 30 days). Tumor dimension remained stable in ultrasound evaluations. A slight reduction in Ki67 immunoexpression was detected, however in only 10/32 post-calcitriol samples an expressively low proliferative index [Ln (%Ki67+) < 1] was achieved. Gene expression from 15 matched pre/post-supplementation samples was analyzed by microarray (U133 Plus 2.0 GeneChip, Affymetrix) and 15 genes were over-expressed in post-supplementation tumors, including FOS and EGR1, which were previously shown to be regulated by vitamin D. However, these results were not confirmed in another four breast cancer samples. CONCLUSIONS: Calcitriol supplementation is neither sufficient to expressively elicit an antiproliferative response nor to induce the hormone transcriptional signaling pathway in breast cancer specimens.
Asunto(s)
Neoplasias de la Mama/metabolismo , Calcitriol/administración & dosificación , Suplementos Dietéticos , Antígeno Ki-67/metabolismo , Transcriptoma , Anciano , Anciano de 80 o más Años , Neoplasias de la Mama/genética , Estudios de Casos y Controles , Proliferación Celular/efectos de los fármacos , Proteína 1 de la Respuesta de Crecimiento Precoz/genética , Proteína 1 de la Respuesta de Crecimiento Precoz/metabolismo , Femenino , Humanos , Antígeno Ki-67/genética , Persona de Mediana Edad , Proteínas Oncogénicas v-fos/genética , Proteínas Oncogénicas v-fos/metabolismo , Posmenopausia , Transducción de SeñalRESUMEN
Germline mutations in BRCA1, BRCA2 and TP53 genes have been identified as one of the most important disease-causing issues in young breast cancer patients worldwide. The specific defective biological processes that trigger germline mutation-associated and -negative tumors remain unclear. To delineate an initial portrait of Brazilian early-onset breast cancer, we performed an investigation combining both germline and tumor analysis. Germline screening of the BRCA1, BRCA2, CHEK2 (c.1100delC) and TP53 genes was performed in 54 unrelated patients <35 y; their tumors were investigated with respect to transcriptional and genomic profiles as well as hormonal receptors and HER2 expression/amplification. Germline mutations were detected in 12 out of 54 patients (22%) [7 in BRCA1 (13%), 4 in BRCA2 (7%) and one in TP53 (2%) gene]. A cancer familial history was present in 31.4% of the unrelated patients, from them 43.7% were carriers for germline mutation (37.5% in BRCA1 and in 6.2% in the BRCA2 genes). Fifty percent of the unrelated patients with hormone receptor-negative tumors carried BRCA1 mutations, percentage increasing to 83% in cases with familial history of cancer. Over-representation of DNA damage-, cellular and cell cycle-related processes was detected in the up-regulated genes of BRCA1/2-associated tumors, whereas cell and embryo development-related processes were over-represented in the up-regulated genes of BRCA1/2-negative tumors, suggesting distinct mechanisms driving the tumorigenesis. An initial portrait of the early-onset breast cancer patients in Brazil was generated pointing out that hormone receptor-negative tumors and positive familial history are two major risk factors for detection of a BRCA1 germline mutation. Additionally, the data revealed molecular factors that potentially trigger the tumor development in young patients.
Asunto(s)
Proteína BRCA1/genética , Proteína BRCA2/genética , Neoplasias de la Mama/genética , Carcinoma/genética , Regulación Neoplásica de la Expresión Génica , Mutación de Línea Germinal , Proteína p53 Supresora de Tumor/genética , Adulto , Edad de Inicio , Brasil/epidemiología , Neoplasias de la Mama/epidemiología , Carcinoma/epidemiología , Transformación Celular Neoplásica/genética , Análisis Mutacional de ADN , Femenino , Perfilación de la Expresión Génica , Humanos , Patrón de Herencia , Linaje , Receptor ErbB-2/deficiencia , Receptor ErbB-2/genéticaRESUMEN
BACKGROUND: Vitamin D transcriptional effects were linked to tumor growth control, however, the hormone targets were determined in cell cultures exposed to supra physiological concentrations of 1,25(OH)(2)D(3) (50-100nM). Our aim was to evaluate the transcriptional effects of 1,25(OH)(2)D(3) in a more physiological model of breast cancer, consisting of fresh tumor slices exposed to 1,25(OH)(2)D(3) at concentrations that can be attained in vivo. METHODS: Tumor samples from post-menopausal breast cancer patients were sliced and cultured for 24 hours with or without 1,25(OH)(2)D(3) 0.5nM or 100nM. Gene expression was analyzed by microarray (SAM paired analysis, FDR≤0.1) or RT-qPCR (p≤0.05, Friedman/Wilcoxon test). Expression of candidate genes was then evaluated in mammary epithelial/breast cancer lineages and cancer associated fibroblasts (CAFs), exposed or not to 1,25(OH)(2)D(3) 0.5nM, using RT-qPCR, western blot or immunocytochemistry. RESULTS: 1,25(OH)(2)D(3) 0.5nM or 100nM effects were evaluated in five tumor samples by microarray and seven and 136 genes, respectively, were up-regulated. There was an enrichment of genes containing transcription factor binding sites for the vitamin D receptor (VDR) in samples exposed to 1,25(OH)(2)D(3) near physiological concentration. Genes up-modulated by both 1,25(OH)(2)D(3) concentrations were CYP24A1, DPP4, CA2, EFTUD1, TKTL1, KCNK3. Expression of candidate genes was subsequently evaluated in another 16 samples by RT-qPCR and up-regulation of CYP24A1, DPP4 and CA2 by 1,25(OH)(2)D(3) was confirmed. To evaluate whether the transcripitonal targets of 1,25(OH)(2)D(3) 0.5nM were restricted to the epithelial or stromal compartments, gene expression was examined in HB4A, C5.4, SKBR3, MDA-MB231, MCF-7 lineages and CAFs, using RT-qPCR. In epithelial cells, there was a clear induction of CYP24A1, CA2, CD14 and IL1RL1. In fibroblasts, in addition to CYP24A1 induction, there was a trend towards up-regulation of CA2, IL1RL1, and DPP4. A higher protein expression of CD14 in epithelial cells and CA2 and DPP4 in CAFs exposed to 1,25(OH)(2)D(3) 0.5nM was detected. CONCLUSIONS: In breast cancer specimens a short period of 1,25(OH)(2)D(3) exposure at near physiological concentration modestly activates the hormone transcriptional pathway. Induction of CYP24A1, CA2, DPP4, IL1RL1 expression appears to reflect 1,25(OH)(2)D(3) effects in epithelial as well as stromal cells, however, induction of CD14 expression is likely restricted to the epithelial compartment.
Asunto(s)
Neoplasias de la Mama/genética , Calcitriol/farmacología , Carcinoma Ductal de Mama/genética , Transcripción Genética/efectos de los fármacos , Vitaminas/farmacología , Neoplasias de la Mama/metabolismo , Calcitriol/administración & dosificación , Carcinoma Ductal de Mama/metabolismo , Regulación hacia Abajo , Células Epiteliales , Femenino , Fibroblastos , Perfilación de la Expresión Génica , Humanos , Análisis de Secuencia por Matrices de Oligonucleótidos , ARN/análisis , Estadísticas no Paramétricas , Técnicas de Cultivo de Tejidos , Células Tumorales Cultivadas , Regulación hacia Arriba , Vitaminas/administración & dosificaciónRESUMEN
Our aim was to evaluate the interaction between breast cancer cells and nodal fibroblasts, by means of their gene expression profile. Fibroblast primary cultures were established from negative and positive lymph nodes from breast cancer patients and a similar gene expression pattern was identified, following cell culture. Fibroblasts and breast cancer cells (MDA-MB231, MDA-MB435, and MCF7) were cultured alone or co-cultured separated by a porous membrane (which allows passage of soluble factors) for comparison. Each breast cancer lineage exerted a particular effect on fibroblasts viability and transcriptional profile. However, fibroblasts from positive and negative nodes had a parallel transcriptional behavior when co-cultured with a specific breast cancer cell line. The effects of nodal fibroblasts on breast cancer cells were also investigated. MDA MB-231 cells viability and migration were enhanced by the presence of fibroblasts and accordingly, MDA-MB435 and MCF7 cells viability followed a similar pattern. MDA-MB231 gene expression profile, as evaluated by cDNA microarray, was influenced by the fibroblasts presence, and HNMT, COMT, FN3K, and SOD2 were confirmed downregulated in MDA-MB231 co-cultured cells with fibroblasts from both negative and positive nodes, in a new series of RT-PCR assays. In summary, transcriptional changes induced in breast cancer cells by fibroblasts from positive as well as negative nodes are very much alike in a specific lineage. However, fibroblasts effects are distinct in each one of the breast cancer lineages, suggesting that the inter-relationships between stromal and malignant cells are dependent on the intrinsic subtype of the tumor.
Asunto(s)
Neoplasias de la Mama/patología , Fibroblastos/patología , Perfilación de la Expresión Génica , Regulación Neoplásica de la Expresión Génica/fisiología , Ganglios Linfáticos/patología , Proteínas de Neoplasias/genética , Adulto , Anciano , Anciano de 80 o más Años , Neoplasias de la Mama/genética , Movimiento Celular , Células Cultivadas , Técnicas de Cocultivo , Femenino , Humanos , Masculino , Persona de Mediana Edad , Proteínas de Neoplasias/metabolismo , Análisis de Secuencia por Matrices de Oligonucleótidos , ARN Mensajero/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Células Tumorales CultivadasRESUMEN
The importance of epithelial-stroma interaction in normal breast development and tumor progression has been recognized. To identify genes that were regulated by these reciprocal interactions, we cocultured a nonmalignant (MCF10A) and a breast cancer derived (MDA-MB231) basal cell lines, with fibroblasts isolated from breast benign-disease adjacent tissues (NAF) or with carcinoma-associated fibroblasts (CAF), in a transwell system. Gene expression profiles of each coculture pair were compared with the correspondent monocultures, using a customized microarray. Contrariwise to large alterations in epithelial cells genomic profiles, fibroblasts were less affected. In MDA-MB231 highly represented genes downregulated by CAF derived factors coded for proteins important for the specificity of vectorial transport between ER and golgi, possibly affecting cell polarity whereas the response of MCF10A comprised an induction of genes coding for stress responsive proteins, representing a prosurvival effect. While NAF downregulated genes encoding proteins associated to glycolipid and fatty acid biosynthesis in MDA-MB231, potentially affecting membrane biogenesis, in MCF10A, genes critical for growth control and adhesion were altered. NAFs responded to coculture with MDA-MB231 by a decrease in the expression of genes induced by TGFbeta1 and associated to motility. However, there was little change in NAFs gene expression profile influenced by MCF10A. CAFs responded to the presence of both epithelial cells inducing genes implicated in cell proliferation. Our data indicate that interactions between breast fibroblasts and basal epithelial cells resulted in alterations in the genomic profiles of both cell types which may help to clarify some aspects of this heterotypic signaling.
Asunto(s)
Neoplasias de la Mama/genética , Neoplasias de la Mama/patología , Células Epiteliales/metabolismo , Fibroblastos/metabolismo , Perfilación de la Expresión Génica , Proteínas de Neoplasias/genética , Biomarcadores de Tumor/genética , Biomarcadores de Tumor/metabolismo , Western Blotting , Mama/citología , Proliferación Celular , Técnicas de Cocultivo , Femenino , Regulación Neoplásica de la Expresión Génica , Humanos , Análisis de Secuencia por Matrices de Oligonucleótidos , ARN Mensajero/genética , ARN Mensajero/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Células Tumorales CultivadasRESUMEN
Pacientes com câncer de mama apresentam menores níveis de 1,25(OH)2D3 ou 25(OH)D3 em relação às mulheres sem a doença. Embora linhagens de câncer de mama apresentem inibição do crescimento em concentrações supra-fisiológicas de 1,25(OH)2D3, forma ativa da vitamina D, ainda não se demonstrou se o hormônio exerce efeito antiproliferativo, em concentrações fisiológicas, em tumores de seres humanos. A suplementação de calcitriol pode ser indica a mulheres pós-menopausadas para prevenir a perda óssea. Nosso objetivo foi avaliar em pacientes com câncer de mama, pós menopausadas, a dimensão do tumor, taxa de proliferação (expressão de Ki67), concentração sérica de 1,25(OH)2D3 e 25(OH)D3, expressão gênica tumoral do receptor de vitamina D (VDR) e alguns genes alvos como, CYP24A1, CYP27B1, IGFBP3, PHB, TGFB2, CDKN1A, CDKN1B, CYP27B1, MYC, CAMP, TXNRD2, antes a após um mês de suplementação oral de calcitriol. Foram estudadas 24 pacientes com doença operável, idade mediana de 57 anos. As primeiras 10 pacientes e as 14 seguintes receberam 0,25 e 0,50g/dia de calcitriol, respectivamente, por um período mediano de 31 dias. Três quartos das pacientes apresentavam nível sérico de insuficiência de 25(OH)D3 ou insuficiência relativa (<30ng/ml) e após a suplementação, nenhuma paciente apresentou elevação dos níveis séricos de 1,25(OH)2D3 e 25(OH)D3. Embora a dimensão tumoral, mensurada por ultrasonografia, não apresentasse variação, a imuno-expressão de Ki67 sofreu um redução relativa mediana de 40%. A expressão relativa de VDR, CYP24A1, CYP27B1, IGFBP3, PHB, TGFB2, CDKN1A, CDKN1B, CYP27B1, MYC, CAMP, TXNRD2 não se alterou com a suplementação. Nossos dados indicam que tumores de mama expressam VDR, e que após suplementação oral de calcitriol, ocorre uma redução da proliferação. Este efeito merece ser elucidado, desde que genes alvo clássicos da 1,25(OH)2D3 não parecem ser mediadores do efeito anti-proliferativo, em amostras de câncer de mama de pacientes pós menopausadas.
Breast cancer patients present lower 1,25(OH)2D3 or 25(OH)D3 serum levels than unaffected women. Although breast cancer cell lines are growth inhibited by vitamin D supra-physiological concentrations, there is much uncertainty about the anti-proliferative effect of physiological concentrations of 1,25(OH)2D3, the active form of vitamin D, in breast cancer specimens in vivo. Vitamin D supplementation to post-menopausal women may be indicated to reduce bone loss. Our aim was to evaluate tumor dimension, proliferation rate (Ki67 expression), 25(OH)D3 and 1,25(OH)2D3 serum concentration, and tumor expression of vitamin D receptor (VDR), and of some target genes as CYP24A1, CYP27B1, IGFBP3, PHB, TGFB2, CDKN1A, CDKN1B, CYP27B1, MYC, CAMP, TXNRD2, before and after a one month calcitriol supplementation to post-menopausal breast cancer patients. Twenty four patients with operable disease, median age 57 years, were enrolled. The first tem patients were supplemented with calcitriol 0.25g/d and the next 14 patients, with 0.50g/d, for a median period of 31 days. Three fourths of the patients presented 25(OH)D3 insufficiency or relative insufficiency (<30 ng/mL) and after calcitriol supplementation, none of them presented an elevation of 1,25(OH)2D3 or 25(OH)D3 serum concentration. Although tumor dimension, evaluated by ultrasonography, did not vary, a median relative reduction of 40% in Ki67 immuno-expression, was observed. No differences in VDR, CYP24A1, CYP27B1, IGFBP3, PHB, TGFB2, CDKN1A, CDKN1B, CYP27B1, MYC, CAMP, TXNRD2 mRNA relative expression were detected between pre and post-supplementation samples. No differences in VDR, CYP27B1 and CYP24A1 tumor relative expression were detected following supplementation. Our data indicate that VDR expression is detected in breast cancer samples and that growth inhibition takes place after calcitriol oral supplementation. This anti-proliferative effect deserves further investigation, as classical target genes do not...
Asunto(s)
Humanos , Femenino , Adulto , Persona de Mediana Edad , Neoplasias de la Mama , Calcitriol , Expresión Génica , Inmunohistoquímica , Posmenopausia , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Vitamina DRESUMEN
1,25(OH)2D3 is an antiproliferative agent that may inhibit proliferation of breast cancer (BC) cells in vitro and BC development in animals. Epidemiological studies have shown a high incidence of BC in people less exposed to solar rays. To unravel the role of Vitamin D3 in BC patients, we have investigated serum levels of 25(OH)D3 and its active form 1,25(OH)2D3 as well as tissue expression of 1alpha-hydroxylase, 24-hydroxylase, and Vitamin D-receptor (VDR), determined by semiquantitative RT-PCR, in 88 Brazilian BC patients and 35 women without cancer (submitted to mammoplasties or resection of benign lesions). Median age of women with and without cancer was 51 and 46 years, respectively, and the majority of BC patients were classified as clinical stage II (67%). Although no differences in 25(OH)D3 serum concentration were found, 1,25(OH)2D3 (40+/-21 pg/ml) levels in BC patients were lower than in women without cancer (53+/-23). Our results indicate that 24-hydroxylase, VDR and 1alpha-hydroxylase mRNA tissue expression is similar in both groups and no correlation between 24-hydroxylase, 1alpha-hydroxylase, and VDR expression in breast tumors was found. A low 1,25(OH)2D3 serum concentration seems to be associated to breast cancer, however, the mechanism involved in this regulation is still unclear.
Asunto(s)
25-Hidroxivitamina D3 1-alfa-Hidroxilasa/metabolismo , Neoplasias de la Mama/metabolismo , Mama/metabolismo , Calcifediol/sangre , Calcitriol/sangre , Receptores de Calcitriol/metabolismo , Esteroide Hidroxilasas/metabolismo , 25-Hidroxivitamina D3 1-alfa-Hidroxilasa/genética , Adulto , Anciano , Antineoplásicos/metabolismo , Brasil , Mama/citología , Neoplasias de la Mama/epidemiología , Neoplasias de la Mama/patología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estadificación de Neoplasias , Estudios Prospectivos , Receptores de Calcitriol/genética , Análisis de Regresión , Esteroide Hidroxilasas/genética , Vitamina D3 24-HidroxilasaRESUMEN
BACKGROUND: Numerous techniques have been described for the treatment of breast hypertrophy and ptosis. Unfortunately, recurrent ptosis after mammaplasty can occur regardless of the technique used. To avoid this problem, different kinds of supporting devices have been described with variable rates of success. However, the true implications of incorporating prosthetic materials into breast surgery have never been clarified. Therefore, surgeons have traditionally been reluctant to apply any kind of prosthetic material to the breast, fearing inflammation, an unfavorable aesthetic outcome, palpable or visible deformities, and interference with the mammographic evaluation of breast cancer. This study analyzed the aesthetic, clinical, and mammographic implications of using mesh as a supportive device in periareolar breast surgery. METHODS: For this study, 18 patients (mean age, 42 years) with breast hypertrophy, ptosis, or both were managed with the double-skin periareolar mammaplasty technique, with placement of mixed (60% Polyglactine and 40% polyester) mesh. Clinical assessment was performed by three breast surgeons actively working on cancer surveillance who knew that the patients had experienced mesh application. After a mean follow-up period of 30 months, a standard mammogram was performed for each patient and analyzed by both the surgeons and an expert radiologist. The evaluated factors were hyperemia, calcifications, contour irregularities, capsular contraction, thickening or widening of the scar with extrusion of the mesh, and any palpable or hardened areas. RESULTS: According to the authors' clinical observations, there were no mesh-related abnormalities in the breast; the mesh was not palpable after the operation; and there was no recurrent ptosis. In terms of mammographic imaging, the mesh was visible as a very fine line in the periphery of the breast's parenchyma (measuring 0.2 mm on the lateral views) in three patients (17%). The mesh did not interfere with the visualization and analysis of the breast's parenchyma. In seven patients (39%), benign localized microcalcifications were detected in the breast and no further investigation was performed. In two patients (11%), grouped calcifications were detected and biopsied, with histopathologic analysis demonstrating epithelial hyperplasia with atypia. In two patients (11%), nodules smaller than 1 cm were detected and biopsied, with histopathologic analysis demonstrating a fibroadenoma in one patient and an invasive ductal carcinoma in the other. CONCLUSIONS: The use of mesh support in breast surgery can enhance the aesthetic results without inducing visible or palpable deformities or mammographic abnormalities. In terms of surveillance mammograms, the presence of the mesh did not interfere with the diagnosis and treatment of minute lesions such as calcifications and small nodules.